Child Results Following Preventive Children of Parents With Psychiatric and Addictive Problems (COPP) Groups

Psychiatric Disorder NOS Clinical Trial

Official title:

Preventive Peer Groups for Children of Parents With Psychiatric and Addictive Problems (COPP). Child Experiences and Observed Child Changes Following the Intervention

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00184405
• Other study ID #: 4.2005.393
• Status: Terminated
• Start date: March 2005
• Est. completion date: December 2008

Study information

• Verified date: May 2023
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a study evaluating changes in quality of life and global functioning across and after a manualized peer-group preventive intervention for children of parents with psychiatric or addictive problems.

Description:

Self-reported quality of life and based on the group-interviews "ILK" and "Kindl" and general adaptive functioning (CGAS) as reported by teachers and parents will be measured before, after and at follow-up relative to the manualized peer-group preventive intervention. Parents will also complete self-reports on anxiety and depressive symptoms, personality, bonding and attribution before the intervention.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 6
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: All
• Age group: 8 Years to 110 Years

Eligibility

Inclusion Criteria:

• Family including Parent with psychiatric or addictive problems

Exclusion Criteria:

• acute severe disorder

Related Conditions & MeSH terms

• Mental Disorders
• Problem Behavior
• Psychiatric Disorder NOS

Locations

Country	Name	City	State
Norway	Norwegian University of Science and Technology (NTNU), Faculty of Medicine, Dept. of Neuroscience, Center for Child and Adolescent Mental Health	Trondheim

Sponsors (2)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology	Helse Nord-Trøndelag HF

Country where clinical trial is conducted

Norway,